rituximab popular tagged News at allvoices.com

rituximab news

News tagged with “rituximab”. Found: 111 tagged news reports.
 

Your Search Returned 111 tagged news reports

 
Related Tags:

Brussels :: Belgium | 23 days ago

Credibility Credibility of 5

MCL is a rare and aggressive blood cancer that usually occurs in older adults. Mantle Cell Lymphoma reinforce our belief that this therapy has the potential to be an important option in the treatment of this cancer." Today's submission is based on

Tags:

London :: United Kingdom | 26 days ago

Credibility Credibility of 5

Following the launch of Herceptin SC in September 2013, MabThera SC is the second novel subcutaneous formulation of one of Roche's oncology products using Halozyme's patented EnhanzeTM (recombinant human hyaluronidase) technology to be launched in

Tags:

Ascó :: Spain | 1 month ago

Credibility Credibility of 5

S&P Biotech Index up 25% over the trailing 12-month period , it's evident that investment dollars are willingly flowing into the biotech sector. Keeping that in mind, let's have a look at some of the rulings, studies, and companies that made waves in

Tags:

London :: United Kingdom | 2 months ago

Credibility Credibility of 5

L US-based biopharmaceutical firm Inhibikase Therapeutics has received orphan drug designation from the US Food and Drug Administration (FDA) for imatinib to treat Progressive Multifocal Leukoencephalopathy (PML). PML is a rare side effect of small

Tags:

London :: United Kingdom | 2 months ago

Credibility Credibility of 5

GSK said that there were no differences in adverse events (AEs) leading to treatment discontinuation, Grade >3 AEs, severe adverse events (SAEs), or fatal SAEs between the treatment arms. Results demonstrate that there were more dose interruptions

Tags:

San Diego :: CA :: USA | 5 months ago

Credibility Credibility of 5

For a young biotech company looking to woo investors, it helps to have promising products...Receptos, a developer of drugs for autoimmune disorders such as multiple sclerosis, has both. That combination helps explain why shares of the La Jolla

Tags:

Rome :: Italy | 6 months ago

Credibility Credibility of 5

Most patients taking rituximab could forego standard (and toxic) immunosuppressive medications. Just one dose of rituximab could provide these benefits for at least one year. Idiopathic nephrotic syndrome has an estimated incidence of 1.5 to 2 per

Tags:

Brussels :: Belgium | 6 months ago

Credibility Credibility of 5

European Commission approve Roche's MabThera (rituximab) 1400mg solution for subcutaneous (SC) injection for the treatment of patients with common forms of non-Hodgkin lymphoma (NHL). At present, the drug is delivered by an intravenous infusion which

Tags:

New York City :: NY :: USA | 6 months ago

Credibility Credibility of 5

This study demonstrates that we may no longer need to use chemotherapy in CLL," said Richard R. Furman, director of CLL Research at Weill Cornell Medical College in New York City. "Even if this cancer remains incurable, it now can be treated as if it

Tags:

Charlottesville :: VA :: USA | 6 months ago

Credibility Credibility of 5

Slow-growing, or indolent, non-Hodgkin lymphomas are difficult to treat, with most patients relapsing repeatedly and the disease becoming increasingly resistant to therapy over time. But a new drug made by Seattle-based Gilead Sciences Inc. appears

Tags:



Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc. 2008-2014. All rights reserved. Powered by PulsePoint.